{"id":"W2538888658","doi":"10.1182/blood.v126.23.4074.4074","title":"Final Results of Anagrelide Controlled-Release (GALE-401) Safety, Efficacy and Pharmacokinetics in Subjects with Myeloproliferative Neoplasms (MPN)-Related Thrombocytosis","year":2015,"lang":"en","type":"article","venue":"Blood","topic":"Myeloproliferative Neoplasms: Diagnosis and Treatment","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"ca_institutions":"inVentiv Health Clinical","funders":"","keywords":"Anagrelide; Medicine; Thrombocytosis; Pharmacokinetics; Cmax; Pharmacology; Myelofibrosis; Platelet; Polycythemia vera; Essential thrombocythemia; Bioequivalence; Internal medicine; Gastroenterology; Bone marrow","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001024709,0.0004110401,0.0004398475,0.0001376313,0.0001651062,0.0003675825,0.0001994062,0.000539955,0.002339009],"category_scores_gemma":[0.0006969446,0.0001401774,0.0003861418,0.0001048068,0.0002267946,0.0002483146,0.0001181995,0.0008154627,0.0004618748],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0002587741,"about_ca_system_score_gemma":0.0002937882,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0002246943,"about_ca_topic_score_gemma":0.0003359597,"domain_scores_codex":[0.9997079,0.0001202437,0.0000215848,0.00006295776,0.00005525198,0.00003204749],"domain_scores_gemma":[0.9996206,0.0001035786,0.00009690908,0.00004204296,0.00005678743,0.00008008739],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"bench_or_experimental","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.2980772,0.02022915,0.01609966,0.0009085111,0.0006543052,0.001065168,0.0004901555,0.001308244,0.5013746,0.0003602518,0.003832308,0.1556005],"study_design_scores_gemma":[0.04907465,0.753738,0.09498153,0.00005945188,0.0006758645,0.001978186,0.0001296093,0.001988621,0.08589849,0.0002183262,0.01119068,0.00006656054],"study_design_candidate":"randomized_trial","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9948402,0.0007091307,0.001035045,0.00008900474,0.00002267407,0.001028373,0.0008258505,0.00009821176,0.001351631],"genre_scores_gemma":[0.9958236,0.0001794607,0.0009514096,0.0001917427,0.00002297808,0.0003610946,0.0008501134,0.00001147642,0.001608085],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.002339009,"threshold_uncertainty_score":0.007824779,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.02599791101880424,"score_gpt":0.2769318746317677,"score_spread":0.2509339636129634,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}